Which scenario is an exception that allows compounding due to inert ingredient concerns or allergies?

• A. There is a drug shortage identified by the FDA
• B. The patient requests a dosage form different from what is commercially available
• C. The patient has an allergy and needs a medication made without a certain inert ingredient
• D. The product is a non-prescription item

Answer: (D)

When compounding is used to address inert ingredient concerns or allergies, the key idea is tailoring a formulation to remove or avoid excipients that a patient cannot tolerate. The scenario that fits this best is when a patient has an allergy to a specific inert ingredient and needs a medication made without that ingredient. This is a direct, patient-centered reason to compound, because it makes the medicine usable and safe for that individual. Other situations—such as addressing a drug shortage, which focuses on having enough supply, or a request for a different dosage form based on preference or market availability—do not revolve around eliminating a problematic excipient. Similarly, while non-prescription products are different in regulatory status, they aren’t inherently about avoiding an inert ingredient due to an allergy, so they don’t illustrate the excipient-specific exception as clearly.